UroGen Pharma (NASDAQ:URGN) reported its Q3 earnings results on Tuesday, November 14, 2023 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

UroGen Pharma beat estimated earnings by 20.0%, reporting an EPS of $-0.68 versus an estimate of $-0.85.

Revenue was up $4.75 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.11 which was followed by a 4.48% increase in the share price the next day.

Here's a look at UroGen Pharma's past performance:

To track all earnings releases for UroGen Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.